I am no longer surprised when providers dont declare me ineligible for medication based on my BMI, as it seems most providers these days do not have a BMI minimum, which can be good and bad
Given the strength of these preliminary signals, the field must now shift focus toward conducting well-powered phase 3 RCTs to validate these associations
They underscore the importance of vigilant monitoring throughout any study involving this peptide
Chuong V, Farokhnia M, Khom S, Pince CL, Elvig SK, Vlkolinsky R, et al
Medicare GLP-1 Bridge Program, Insurance, and How Omzo Fits In Starting July 1, 2026, eligible Medicare beneficiaries can get select FDA-approved GLP-1 medications - Wegovy, Foundayo, and Zepbound KwikPen - for $50 per month through the CMS Medicare GLP-1 Bridge Program
In this article, we discuss the current regulatory and enforcement environment and discuss ways that weight loss providers and clinics can reduce their level of risk